跳至主要内容
临床试验/NCT01156337
NCT01156337已完成不适用

Sodium Management in Acute and Chronic Phases in Patients With New York Heart Association Class III (Class C) Heart Failure. Short and Long Term Findings.

Ospedale G. F. Ingrassia1 个研究点 分布在 1 个国家开始时间: 2000年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
试验地点
1
主要终点
readmission for HF worsening

研究概览

简要总结

The study was aimed to verify the effects of Hypertonic saline solution (HSS) and a moderate sodium (Na) restriction plus high furosemide dose in the short term (hospitalization time) and a moderate Na restriction in the long term on readmissions and mortality in patients in III NYHA class.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Decompensated HF due to ischemic or nonischemic cardiomyopathy,
  • >18 years of age,
  • HF according to Framingham criteria
  • NYHA functional class III
  • EF <40%,
  • Serum creatinine <2,5 mg/dL
  • BUN <60 mg/dL,
  • Exclusion criteria:
  • NYHA class > III or < III,
  • Cerebral vascular disease,
  • Dementia,
  • Uncompensated diabetes,
  • Severe hepatic disease
  • Patients requiring pacemaker
  • Previous RCT implantation
  • Alcoholic habit

排除标准

  • 未提供

结局指标

主要结局

readmission for HF worsening

次要结局

  • mortality

研究者

发起方
Ospedale G. F. Ingrassia
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Sodium Management in Acute and Chronic Heart Failure | 临床试验